跳至主要内容
临床试验/NCT00157898
NCT00157898已完成4 期

A Prospective, Multicenter, Open, Randomized, Comparative Study to Evaluate the Safety and Efficacy of Ertapenem Versus it's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults

Merck Sharp & Dohme LLC0 个研究点目标入组 134 人开始时间: 2004年1月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
134
主要终点
Favorable clinical response at 7-14 days after treatment

研究概览

简要总结

This was a prospective, randomized, controlled, open, and multi-center trial conducted to compare the clinical efficacy and safety of ertapenem with it's comparator before or following adequate surgical management of complicated intra-abdominal infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females between the ages of 18 and 75 who have complicated intra-abdominal infection.

排除标准

  • 未提供

结局指标

主要结局

Favorable clinical response at 7-14 days after treatment

次要结局

  • Favorable microbiologic response at 7-14 days after treatment

研究者

申办方类型
Industry
责任方
Sponsor

相似试验